| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/20/2011 | EP2311453A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2310416A1 Anti-gd2 antibodies and methods and uses related thereto |
| 04/20/2011 | EP2310405A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 04/20/2011 | EP2310402A1 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 04/20/2011 | EP2310391A1 Pyrazine substituted purines |
| 04/20/2011 | EP2310389A1 Heterocycles as protein kinase inhibitors |
| 04/20/2011 | EP2310383A1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 04/20/2011 | EP2310382A1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 04/20/2011 | EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
| 04/20/2011 | EP2310380A1 Schweinfurthin analogues |
| 04/20/2011 | EP2310377A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
| 04/20/2011 | EP2310375A1 Chemical compounds |
| 04/20/2011 | EP2310373A1 Bicyclic heterocycles as mek kinase inhibitors |
| 04/20/2011 | EP2310370A1 4, 6-diphenylpyrid-2-ones against cancer |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310364A1 Heterocyclic derivatives as hdac inhibitors |
| 04/20/2011 | EP2310363A2 Anticancer oral formulation |
| 04/20/2011 | EP2310044A2 Anti-tumor immunotherapy |
| 04/20/2011 | EP2310029A2 Suppression of cancers |
| 04/20/2011 | EP2310028A2 Suppression of neuroendocrine diseases |
| 04/20/2011 | EP2310027A1 Extract of phaleria macrocarpa as an antineoplastic, anti-inflammatory and antiangiogenic agent |
| 04/20/2011 | EP2310023A2 Composition useful for the prevention or reduction of the progression of prostate cancer |
| 04/20/2011 | EP2310020A2 Novel acetates of 2-deoxy monosaccharides with anticancer activity |
| 04/20/2011 | EP2310013A1 Bicyclic triazole derivatives for treating tumors |
| 04/20/2011 | EP2310011A2 Antineoplastic combinations containing hki-272 and vinorelbine |
| 04/20/2011 | EP2310010A2 Chemical compounds 251 |
| 04/20/2011 | EP2310009A2 Parenteral and oral formulations of benzimidazoles |
| 04/20/2011 | EP2310006A2 Treating cancer |
| 04/20/2011 | EP2309856A1 Pharmaceutical compounds as cytotoxic agents and the use thereof |
| 04/20/2011 | EP2309854A1 Accelerated therapy |
| 04/20/2011 | EP2309853A1 Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase |
| 04/20/2011 | EP2220070B1 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 04/20/2011 | EP2077293B1 Block copolymer for drug conjugates and their pharmaceutical compositions |
| 04/20/2011 | EP1874312B1 Treatment of hpv induced anogenital intraepithelial neoplasia |
| 04/20/2011 | EP1859793B1 Novel combinational use of a sulfonamide compound in the treatment of cancer |
| 04/20/2011 | EP1824975B9 Lna oligonucleotides and the treatment of cancer |
| 04/20/2011 | EP1784396B8 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 04/20/2011 | EP1624892B1 Therapeutic use of anti-cs1 antibodies |
| 04/20/2011 | EP1592423B1 Combination therapy of zd6474 with 5-fu and/or cpt-11 |
| 04/20/2011 | EP1569657B1 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 04/20/2011 | EP1449534B1 Ganoderma atrum extract as matrix metalloprotease inhibitor |
| 04/20/2011 | EP1385993B1 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 04/20/2011 | EP1082415B1 Methods useful for modulation of angiogenesis using tyrosine kinase src |
| 04/20/2011 | CN1955183B 20-bit esterified camptothecine derivate, its preparation method and drug composite and use |
| 04/20/2011 | CN1915978B Crystal form of lonidamine, preparation method, and composition of containing the crystal form |
| 04/20/2011 | CN1872107B Chinese and Western compound preparations of alpha receptor blocking pharmacon, preparation method, and application |
| 04/20/2011 | CN1854130B Chinazoline derivative, its production, medicinal composition and use |
| 04/20/2011 | CN1849395B HLA-a24 binding cancer antigen peptide derived from ribin |
| 04/20/2011 | CN1698620B Cucurbitacin emulsion capable of filtering out and eliminating bacteria and preparation method thereof |
| 04/20/2011 | CN1628179B Detection of hepatocellular carcinoma |
| 04/20/2011 | CN102027019A High-density lipoprotein-like peptide-phospholipid scaffold (''HPPS'') nanoparticles |
| 04/20/2011 | CN102027015A Anti-CXCR4 antibodies |
| 04/20/2011 | CN102026999A Azetidine and cyclobutane derivatives as JAK inhibitors |
| 04/20/2011 | CN102026998A Spirocyclic derivatives as histone deacetylase inhibitors |
| 04/20/2011 | CN102026992A Novel HSP inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 04/20/2011 | CN102026985A Quinazoline derivatives as RAF kinase modulators and methods of use thereof |
| 04/20/2011 | CN102026983A Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
| 04/20/2011 | CN102026969A Novel N-(2-amino-phenyl)-acrylamides |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102026672A C2ORF18 as target gene for cancer therapy and diagnosis |
| 04/20/2011 | CN102026669A Conjugates for the treatment of mesothelioma |
| 04/20/2011 | CN102026667A Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 04/20/2011 | CN102026659A Method for the prevention and treatment of cancer by inhibition of GPVI |
| 04/20/2011 | CN102026647A Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 04/20/2011 | CN102026645A Oncolytic rhabdovirus |
| 04/20/2011 | CN102026634A Induction of tumor hypoxia for cancer therapy |
| 04/20/2011 | CN102021162A High-activity bifidobacterium powder and preparation method thereof |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102021149A Gene NSI deficit type respiratory syncytial virus and application thereof to treating lung cancer |
| 04/20/2011 | CN102021148A Gene NS1 (Structural Protein) defective respiratory syncytial virus and application thereof |
| 04/20/2011 | CN102021137A Method for preparing glycyrrhiza total flavonoids from glycyrrhiza hairy roots and culture solution thereof |
| 04/20/2011 | CN102020765A Preparation methods of poly (aspartic acid-co-lactic acid) graft polymer and nanoparticles of poly (aspartic acid-co-lactic acid) graft polymer |
| 04/20/2011 | CN102020711A Casing smooth muscle collagen preparation method and functional study |
| 04/20/2011 | CN102020689A 1,2-trans rhamnose indican derivative of anthone compounds and preparation method thereof |
| 04/20/2011 | CN102020657A Condensed heteroaryl derivative, and preparation method and application thereof |
| 04/20/2011 | CN102020653A New application of amino perhydrogenated quinazoline compound and derivative preparation thereof for improving drug effects of anticancer drugs |
| 04/20/2011 | CN102020651A 6-aryl amino pyridone formamide MEK (methyl ethyl ketone) inhibitor |
| 04/20/2011 | CN102020649A Diketopiperazine compound as well as composition, preparation method and application thereof |
| 04/20/2011 | CN102020648A 3-aryl-6-aryl-[1,2,4] triazol [4,3-b] pyridazine taken as cell proliferation inhibitor and application of cell proliferation inhibitor |
| 04/20/2011 | CN102020643A dihydropteridine ketone derivative, and preparation method and medicinal application thereof |
| 04/20/2011 | CN102020640A Tetrahydroindolone and tetrahydroindolone derivative as well as preparation method and medical application thereof |
| 04/20/2011 | CN102020639A 6-amido quinazoline or 3-cyano quinoline derivative, preparation method thereof and application of derivative to medicament |
| 04/20/2011 | CN102020638A 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020623A Butterbur extract as well as preparation method and application thereof |
| 04/20/2011 | CN102020607A 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 04/20/2011 | CN102020598A Gronwell naphthaquinone derivative, preparation method of gronwell naphthaquinone derivative and application of gronwell naphthaquinone derivative serving as anticarcinoma drug |
| 04/20/2011 | CN102020588A Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020577A Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 04/20/2011 | CN102020563A Novel curcumin analogues and uses thereof |
| 04/20/2011 | CN102018965A Application of miRNA-10a in preparation of drug inhabiting intrusion and transfer of colorectal cancer |
| 04/20/2011 | CN102018877A Traditional Chinese medicine for promoting psychological and physiological wounds to heal |
| 04/20/2011 | CN102018864A Traditional Chinese medicine for curing esophagus cancer and processing method of traditional Chinese medicine |
| 04/20/2011 | CN102018793A Medicine and rectum drop detoxification solution used for treating tumour and drop appliance of rectum drop detoxification solution |
| 04/20/2011 | CN102018764A Medicine for the prevention and treatment of tumor and preparation method of the same |
| 04/20/2011 | CN102018759A Rosmarinic acid, rosmarinic acid-containing common selfheal fruit-spike active ingredient and preparation methods and application thereof to prevention and treatment of cancer postoperative metastasis |
| 04/20/2011 | CN102018737A Inductive extraction method for alkaloid active ingredients of catharanthus roseus |
| 04/20/2011 | CN102018736A Natural indigo decoction piece and preparation method thereof |
| 04/20/2011 | CN102018734A Application of brucea javanica oil emulsion complex formula in preparing drugs for treating portal vein tumor thrombus of liver cancer |
| 04/20/2011 | CN102018723A Preparation method for marine microorganism natural and polymorphic arsenic compound extract for inhibiting tumors and application thereof |